Search Results

There are 32453 results for: content related to: Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa

  1. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 10, October 2009, Pages: 953–965, X. Ma, H. Hui, Z. Liu, G. He, J. Hu, J. Meng, L. Guan and X. Luo

    Version of Record online : 16 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01070.x

  2. Mechanisms for the cardiovascular effects of glucagon-like peptide-1

    Acta Physiologica

    Volume 216, Issue 3, March 2016, Pages: 277–313, H. Poudyal

    Version of Record online : 8 OCT 2015, DOI: 10.1111/apha.12604

  3. Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication

    Journal of Comparative Neurology

    Volume 521, Issue 10, 1 July 2013, Pages: 2235–2261, Guibao Gu, Barbara Roland, Kevin Tomaselli, Carrie S. Dolman, Carolyn Lowe and Joseph S. Heilig

    Version of Record online : 19 APR 2013, DOI: 10.1002/cne.23282

  4. You have free access to this content
    Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

    British Journal of Pharmacology

    Volume 157, Issue 8, August 2009, Pages: 1340–1351, David J Grieve, Roslyn S Cassidy and Brian D Green

    Version of Record online : 29 JUL 2009, DOI: 10.1111/j.1476-5381.2009.00376.x

  5. You have full text access to this OnlineOpen article
    PRP-17 and the pre-mRNA splicing pathway are preferentially required for the proliferation versus meiotic development decision and germline sex determination in Caenorhabditis elegans

    Developmental Dynamics

    Volume 239, Issue 5, May 2010, Pages: 1555–1572, Jessica Amrozowicz Kerins, Momoyo Hanazawa, Maia Dorsett and Tim Schedl

    Version of Record online : 30 MAR 2010, DOI: 10.1002/dvdy.22274

  6. You have free access to this content
    GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities

    British Journal of Pharmacology

    Volume 166, Issue 1, May 2012, Pages: 121–136, Jonathan D Roth, Mary R Erickson, Steve Chen and David G Parkes

    Version of Record online : 10 APR 2012, DOI: 10.1111/j.1476-5381.2011.01537.x

  7. Glucagon-like peptide 1(GLP-1) in biology and pathology

    Diabetes/Metabolism Research and Reviews

    Volume 21, Issue 2, March/April 2005, Pages: 91–117, Juris J. Meier and Michael A. Nauck

    Version of Record online : 9 MAR 2005, DOI: 10.1002/dmrr.538

  8. You have full text access to this Open Access content
    GIP and GLP-1, the two incretin hormones: Similarities and differences

    Journal of Diabetes Investigation

    Volume 1, Issue 1-2, February/April 2010, Pages: 8–23, Yutaka Seino, Mitsuo Fukushima and Daisuke Yabe

    Version of Record online : 22 APR 2010, DOI: 10.1111/j.2040-1124.2010.00022.x

  9. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 1, January 2011, Pages: 26–33, E. Tomas, J. A. Wood, V. Stanojevic and J. F. Habener

    Version of Record online : 28 NOV 2010, DOI: 10.1111/j.1463-1326.2010.01316.x

  10. You have free access to this content
    Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia

    Diabetes, Obesity and Metabolism

    Volume 13, Issue s1, October 2011, Pages: 60–68, P. B. Jensen, P. J. Larsen, C. Karlsen, H. I. Jensen, J. J. Holst and O. D. Madsen

    Version of Record online : 8 AUG 2011, DOI: 10.1111/j.1463-1326.2011.01439.x

  11. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 9–21, S. Madsbad

    Version of Record online : 26 MAY 2013, DOI: 10.1111/dom.12119

  12. You have full text access to this Open Access content
    Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

    Journal of Diabetes Investigation

    Volume 3, Issue 1, February 2012, Pages: 70–79, Daisuke Yabe, Koin Watanabe, Kenji Sugawara, Hitoshi Kuwata, Yuka Kitamoto, Kazu Sugizaki, Shuichi Fujiwara, Masahiro Hishizawa, Takanori Hyo, Kyoko Kuwabara, Kayo Yokota, Masahiro Iwasaki, Naomi Kitatani, Takeshi Kurose, Nobuya Inagaki and Yutaka Seino

    Version of Record online : 4 JUL 2011, DOI: 10.1111/j.2040-1124.2011.00141.x

  13. You have free access to this content
    Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance

    The Journal of Physiology

    Volume 593, Issue 9, 1 May 2015, Pages: 2185–2198, Kim A. Sjøberg, Stephen Rattigan, Jacob F. Jeppesen, Anne-Marie Lundsgaard, Jens J. Holst and Bente Kiens

    Version of Record online : 19 MAR 2015, DOI: 10.1113/JP270129

  14. You have free access to this content
    Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation

    British Journal of Pharmacology

    Volume 171, Issue 5, March 2014, Pages: 1114–1128, K Pabreja, M A Mohd, C Koole, D Wootten and S G B Furness

    Version of Record online : 27 FEB 2014, DOI: 10.1111/bph.12313

  15. You have free access to this content
    The future of incretin-based therapy: novel avenues—novel targets

    Diabetes, Obesity and Metabolism

    Volume 13, Issue s1, October 2011, Pages: 158–166, B. Ahrén

    Version of Record online : 8 AUG 2011, DOI: 10.1111/j.1463-1326.2011.01457.x

  16. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 8, August 2015, Pages: 789–799, E. Tudurí, D. Beiroa, B. Porteiro, M. López, C. Diéguez and R. Nogueiras

    Version of Record online : 25 JUN 2015, DOI: 10.1111/dom.12488

  17. You have free access to this content
    Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 721–736, Mitchel Tate, Aaron Chong, Emma Robinson, Brian D Green and David J Grieve

    Version of Record online : 1 DEC 2014, DOI: 10.1111/bph.12943

  18. Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients在1型糖尿病患者中代谢综合征与进餐诱导的胰高血糖素样肽-1应答之间的关系

    Journal of Diabetes

    Volume 7, Issue 3, May 2015, Pages: 340–346, Kristina Blaslov, Tomislav Bulum, Karin Zibar and Lea Duvnjak

    Version of Record online : 3 OCT 2014, DOI: 10.1111/1753-0407.12194

  19. You have full text access to this OnlineOpen article
    Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast

    British Journal of Pharmacology

    Volume 171, Issue 15, August 2014, Pages: 3651–3665, C Weston, D Poyner, V Patel, S Dowell and G Ladds

    Version of Record online : 17 JUL 2014, DOI: 10.1111/bph.12716

  20. (Val8)GLP-1-Glu-PAL: a GLP-1 Agonist That Improves Hippocampal Neurogenesis, Glucose Homeostasis, and β-Cell Function in High-Fat-Fed Mice

    ChemMedChem

    Volume 8, Issue 4, April 2013, Pages: 595–602, Rachael Lennox, Dr. David W. Porter, Prof. Peter R. Flatt and Dr. Victor A. Gault

    Version of Record online : 8 NOV 2012, DOI: 10.1002/cmdc.201200409